Total Payments
$59,034
2024 Payments
$31,575
Companies
48
Transactions
818
Medicare Patients
26,583
Medicare Billing
$4.0M
Payment Breakdown by Category
Other$38,150 (64.6%)
Food & Beverage$15,664 (26.5%)
Travel$3,270 (5.5%)
Consulting$1,800 (3.0%)
Education$149.74 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Long term medical supply or device loan | $29,750 | 1 | 50.4% |
| Food and Beverage | $15,664 | 799 | 26.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $8,400 | 4 | 14.2% |
| Travel and Lodging | $3,270 | 9 | 5.5% |
| Consulting Fee | $1,800 | 1 | 3.0% |
| Education | $149.74 | 4 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AngioDynamics, Inc. | $29,841 | 6 | $0 (2024) |
| Penumbra, Inc. | $9,781 | 17 | $0 (2024) |
| Boston Scientific Corporation | $7,732 | 123 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,336 | 80 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,140 | 68 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $903.87 | 53 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $888.29 | 54 | $0 (2023) |
| Medtronic, Inc. | $711.72 | 56 | $0 (2024) |
| Amgen Inc. | $704.47 | 52 | $0 (2024) |
| ABIOMED | $668.51 | 30 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $31,575 | 99 | AngioDynamics, Inc. ($29,800) |
| 2023 | $1,800 | 96 | Boston Scientific Corporation ($304.20) |
| 2022 | $3,254 | 114 | Penumbra, Inc. ($1,550) |
| 2021 | $10,254 | 127 | Penumbra, Inc. ($7,999) |
| 2020 | $1,542 | 79 | Boston Scientific Corporation ($206.70) |
| 2019 | $1,698 | 107 | Philips Electronics North America Corporation ($283.16) |
| 2018 | $3,158 | 94 | BOSTON SCIENTIFIC CORPORATION ($1,943) |
| 2017 | $5,752 | 102 | BOSTON SCIENTIFIC CORPORATION ($4,156) |
All Payment Transactions
818 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | AngioDynamics, Inc. | Auryon Laser System 100-120 Vac (Device) | Long term medical supply or device loan | In-kind items and services | $29,750.00 | General |
| Category: ET | ||||||
| 12/18/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: Renal Denervation System | ||||||
| 12/11/2024 | Boston Scientific Corporation | AVVIGO Guidance System (Device) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: AVVIGO_IC | ||||||
| 12/10/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $12.18 | General |
| Category: Cardiology | ||||||
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: DIABETES | ||||||
| 12/02/2024 | Boston Scientific Corporation | ELUVIA (Device) | Food and Beverage | In-kind items and services | $32.21 | General |
| Category: ELUVIA_PI | ||||||
| 12/02/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $13.27 | General |
| Category: Cardiovascular | ||||||
| 11/19/2024 | Medtronic, Inc. | VENASEAL (Device) | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: EndoVenous Therapies | ||||||
| 11/14/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $35.89 | General |
| Category: Cardiology | ||||||
| 11/12/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: Cardiology | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/06/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $27.32 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/31/2024 | Penumbra, Inc. | Penumbra System (Device) | Food and Beverage | Cash or cash equivalent | $23.78 | General |
| Category: Neurointervention | ||||||
| 10/31/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: DIABETES | ||||||
| 10/30/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: Renal Denervation System | ||||||
| 10/28/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.97 | General |
| Category: Cardiovascular | ||||||
| 10/23/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $9.52 | General |
| Category: Renal Denervation System | ||||||
| 10/22/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/15/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Cardiology | ||||||
| 10/10/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/08/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $28.79 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/03/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $22.69 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/02/2024 | Terumo Medical Corporation | NAVICROSS (Device) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: VASCULAR ACCESS | ||||||
| 09/18/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $13.47 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 57 | 6,073 | 15,982 | $8.0M | $1.5M |
| 2022 | 65 | 7,651 | 16,465 | $6.5M | $1.5M |
| 2021 | 55 | 5,979 | 9,239 | $1.3M | $471,370 |
| 2020 | 49 | 6,880 | 9,956 | $1.3M | $527,298 |
Total Patients
26,583
Total Services
51,642
Medicare Billing
$4.0M
Procedure Codes
238
All Medicare Procedures & Services
238 procedure records from CMS Medicare Utilization — Page 1 of 10
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 37229 | Removal of plaque in artery of leg, initial vessel | Office | 2023 | 48 | 65 | $2.0M | $396,560 | 19.5% |
| 37225 | Removal of plaque in arteries of leg | Office | 2023 | 61 | 83 | $2.5M | $371,477 | 14.6% |
| 36465 | Injection of chemical agent into single incompetent vein of leg using ultrasound guidance | Office | 2023 | 82 | 117 | $538,337 | $105,491 | 19.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 595 | 622 | $237,794 | $80,096 | 33.7% |
| 36482 | Chemical destruction of first incompetent vein of arm or leg using imaging guidance | Office | 2023 | 38 | 60 | $353,270 | $69,595 | 19.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 565 | 654 | $194,663 | $55,829 | 28.7% |
| 37228 | Balloon dilation of artery of leg, initial vessel | Office | 2023 | 18 | 19 | $277,275 | $50,614 | 18.3% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 221 | 224 | $119,168 | $33,368 | 28.0% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 251 | 267 | $114,556 | $32,535 | 28.4% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 154 | 250 | $105,138 | $30,777 | 29.3% |
| 37252 | Ultrasound evaluation of blood vessel with review by radiologist, initial vessel | Office | 2023 | 37 | 41 | $136,687 | $27,232 | 19.9% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 147 | 163 | $56,235 | $26,005 | 46.2% |
| 36247 | Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | Office | 2023 | 26 | 26 | $130,697 | $25,524 | 19.5% |
| 37224 | Balloon dilation of artery of leg | Office | 2023 | 17 | 18 | $184,824 | $22,529 | 12.2% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 34 | 40 | $51,444 | $15,912 | 30.9% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 84 | 85 | $58,535 | $14,823 | 25.3% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Office | 2023 | 101 | 185 | $49,354 | $13,677 | 27.7% |
| 75710 | Review by radiologist of arm or leg artery image | Office | 2023 | 70 | 88 | $48,312 | $9,633 | 19.9% |
| 75716 | Review by radiologist of both arms or legs arteries image | Office | 2023 | 69 | 75 | $44,713 | $8,853 | 19.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 145 | 148 | $31,092 | $8,766 | 28.2% |
| 37253 | Ultrasound evaluation of blood vessel with review by radiologist, each additional vessel | Office | 2023 | 35 | 71 | $43,531 | $8,684 | 19.9% |
| 36246 | Insertion of tube into abdominal, pelvic, or leg artery, initial second order branch | Office | 2023 | 15 | 15 | $44,701 | $8,275 | 18.5% |
| 75625 | Review by radiologist of abdominal aorta image | Office | 2023 | 95 | 100 | $45,890 | $8,134 | 17.7% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 49 | 1,055 | $58,025 | $7,860 | 13.5% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 977 | 1,246 | $123,304 | $7,023 | 5.7% |
About Dr. John King, MD
Dr. John King, MD is a Interventional Cardiology healthcare provider based in Columbus, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1861505448.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John King, MD has received a total of $59,034 in payments from pharmaceutical and medical device companies, with $31,575 received in 2024. These payments were reported across 818 transactions from 48 companies. The most common payment nature is "Long term medical supply or device loan" ($29,750).
As a Medicare-enrolled provider, King has provided services to 26,583 Medicare beneficiaries, totaling 51,642 services with total Medicare billing of $4.0M. Data is available for 4 years (2020–2023), covering 238 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Cardiology
- Location Columbus, MS
- Active Since 08/16/2006
- Last Updated 06/21/2019
- Taxonomy Code 207RI0011X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1861505448
Products in Payments
- Auryon Laser System 100-120 Vac (Device) $29,750
- Indigo System (Device) $9,595
- FFR LINK (Device) $2,023
- GENERAL - VASCULAR ACCESS (Device) $1,686
- GENERAL THERAPIES (Device) $1,417
- XARELTO (Drug) $903.87
- LifeVest (Device) $888.29
- ENTRESTO (Drug) $877.23
- Impella (Device) $668.51
- Repatha (Biological) $570.80
- VERQUVO (Drug) $570.64
- JARDIANCE (Drug) $564.53
- BRILINTA (Drug) $501.70
- LEQVIO (Drug) $458.61
- FARXIGA (Drug) $452.82
- VIGILANT (Device) $313.21
- VENASEAL (Device) $307.64
- ELCAELCA X-80 (Device) $305.37
- IGT D Coronary (Device) $269.90
- ELIQUIS (Drug) $247.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Interventional Cardiology Doctors in Columbus
Dr. Carlos Sanchez Soto, Md, MD
Interventional Cardiology — Payments: $983,320
Interventional Cardiology $983,320
Christopher Huff, M.d, M.D
Interventional Cardiology — Payments: $119,120
Interventional Cardiology $119,120
Dr. Aref Amro, Md, MD
Interventional Cardiology — Payments: $118,914
Interventional Cardiology $118,914
Dr. Shane Darrah, M.d, M.D
Interventional Cardiology — Payments: $27,458
Interventional Cardiology $27,458
Deepak Pattanshetty, Md, Mrcp(Uk), MD, MRCP(UK)
Interventional Cardiology — Payments: $18,087
Interventional Cardiology $18,087
Justin Morrison, M.d, M.D
Interventional Cardiology — Payments: $13,065
Interventional Cardiology $13,065